Sustained Function and Enhanced Replicative Capacity of Anti-Tumor CD4+Effectors by Enforced Co-Stimulation

被引：0
|
作者：
Chang, Lufen [1 ]
Jensen, Michael [1 ]
机构：
[1] City Hope Natl Med Ctr, Div Canc Immunotherapeut & Tumor Immunol, Beckman Res Inst City Hope, Duarte, CA 91010 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.707
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
632
引用
收藏
页码：S243 / S244
页数：2
相关论文
共 50 条
  • [21] Effective anti-tumor vaccination by CIITA-transfected tumor cells as result of optimal CD4+T helper cell stimulation
    Accolla, R.
    Merello, L.
    Lombardo, L.
    Tosi, G.
    IMMUNOLOGY, 2012, 137 : 607 - 607
  • [22] Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8+ T cells
    Trsan, Tihana
    Vukovic, Kristina
    Filipovic, Petra
    Brizic, Ana Lesac
    Lemmermann, Niels A. W.
    Schober, Kilian
    Busch, Dirk H.
    Britt, William J.
    Messerle, Martin
    Krmpotic, Astrid
    Jonjic, Stipan
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 (08) : 1354 - 1367
  • [23] Blockade of 6-phosphogluconate dehydrogenase generates CD8+ effector T cells with enhanced anti-tumor function
    Daneshmandi, Saeed
    Cassel, Teresa
    Lin, Penghui
    Higashi, Richard M.
    Wulf, Gerburg M.
    Boussiotis, Vassiliki A.
    Fan, Teresa W-M
    Seth, Pankaj
    CELL REPORTS, 2021, 34 (10):
  • [24] SIRP? DEFICIENT CAR-MACROPHAGES EXHIBIT ENHANCED ANTI-TUMOR FUNCTION AND BYPASS THE CD47 IMMUNE CHECKPOINT
    Sloas, Chris
    Gabbasov, Rashid
    Anderson, Nicholas
    Abramson, Sascha
    Klichinsky, Michael
    Ohtani, Yumi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A152 - A152
  • [25] Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals
    Song, Aihua
    Song, Jianxun
    Tang, Xiaohong
    Croft, Michael
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (05) : 1224 - 1232
  • [26] CD4+T cell help differentially influences anti-tumor immunity as a function of T cell avidity
    Zhu, Ziqiang
    Singh, Vinod
    Bronte, Vincenzo
    Feigenbaum, Lionel
    Hurwitz, Arthur
    CANCER RESEARCH, 2011, 71
  • [27] Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy
    Chacon, Jessica Ann
    Wu, Richard C.
    Sukhumalchandra, Pariya
    Molldrem, Jeffrey J.
    Sarnaik, Amod
    Pilon-Thomas, Shari
    Weber, Jeffrey
    Hwu, Patrick
    Radvanyi, Laszlo
    PLOS ONE, 2013, 8 (04):
  • [28] Toll like receptor 2 co-stimulation signaling in CD4+ T cells promote TH9 differentiation and function
    Karim, Ahmad Faisal
    Reba, Scott M.
    Ding, Xuedong
    Rojas, Roxana E.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [29] Fc-silenced bispecific antibodies targeting PD-L1 and 4-1BB combine checkpoint blockade and T-cell co-stimulation to promote anti-tumor activity
    Muik, Alexander
    Altintas, Isil
    Gieseke, Friederike
    Salcedo, Theodora
    Burm, Saskia
    Diken, Mustafa
    Grunwitz, Christian
    Schuurhuis, Danita
    Kreiter, Sebastian
    Satijn, David
    Tureci, Ozlem
    Breij, Esther
    Sahin, Ugur
    Jure-Kunkel, Maria
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [30] An Fc-inert PD-L1x4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation
    Muik, Alexander
    Altintas, Isil
    Gieseke, Friederike
    Schoedel, Kristina B.
    Burm, Saskia M.
    Toker, Aras
    Salcedo, Theodora W.
    Verzijl, Dennis
    Eisel, David
    Grunwitz, Christian
    Kranz, Lena M.
    Vormehr, Mathias
    Satijn, David P. E.
    Diken, Mustafa
    Kreiter, Sebastian
    Sasser, Kate
    Ahmadi, Tahamtan
    Tuereci, Oezlem
    Breij, Esther C. W.
    Jure-Kunkel, Maria
    Sahin, Ugur
    ONCOIMMUNOLOGY, 2022, 11 (01):
12345